Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Report of Loss or Disappearance of Listed Chemicals and Regulated Transactions in Tableting/Encapsulating Machines; DEA Forms 107, 452, 34238-34239 [2020-11932]
Download as PDF
34238
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Comments are encouraged and
will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A. Brinks, Regulatory Drafting and
Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
DATES:
lotter on DSK9F5VC42PROD with NOTICES
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Permit to Import
Controlled Substances for Domestic
and/or Scientific Purposes Pursuant to
21 U.S.C. 952.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form: 357. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
VerDate Sep<11>2014
18:35 Jun 02, 2020
Jkt 250001
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and
Title 21, Code of Federal Regulations
(21 CFR), Sections 1312.11, 1312.12 and
1312.13 requires any person who
desires to import controlled substances
listed in schedules I or II, any narcotic
substance listed in schedules III or IV,
or any non-narcotic substance in
schedule III which the Administrator
has specifically designated by regulation
in § 1312.30, or any nonnarcotic
substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to DEA on
DEA Form 357.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 171
registrants participate in this
information collection, taking an
estimated 0.26 hours per registrant
annually.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates the
total public burden (in hours) associated
with this collection: 497 annual burden
hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: May 28, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–11923 Filed 6–2–20; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[OMB Number 1117–0024]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Report of Loss
or Disappearance of Listed Chemicals
and Regulated Transactions in
Tableting/Encapsulating Machines;
DEA Forms 107, 452
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott Brinks, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION:
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
SUMMARY:
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
permitting electronic submission of
responses.
lotter on DSK9F5VC42PROD with NOTICES
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection: Report
of Loss or Disappearance of Listed
Chemicals and Regulated Transactions
in Tableting/Encapsulating Machines.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms 107 and 452. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Each regulated person is
required to report any unusual or
excessive loss or disappearance of a
listed chemical, and any regulated
transaction in a tableting or
encapsulating machine, to include any
domestic regulated transaction in a
tableting or encapsulating machine and
any import or export of a tableting or
encapsulating machine. 21 U.S.C. 830
(b)(1)(A), (C) and (D); 21 CFR
1310.05(a)(1), (3)–(4); 21 CFR
1310.05(c).
Regulated persons include
manufacturers, distributors, importers,
and exporters of listed chemicals,
tableting machines, or encapsulating
machines, or persons who serve as
brokers or traders for international
transactions involving a listed chemical,
tableting machine, or encapsulating
machine. 21 CFR 1300.02(b). Both
reports will be submitted electronically.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 2,331
persons respond as needed to this
collection. Responses take 20 minutes.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates that
this collection takes 1,276 annual
burden hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
VerDate Sep<11>2014
18:35 Jun 02, 2020
Jkt 250001
Dated: May 28, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–11932 Filed 6–2–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection, Import/Export
Declaration for List I and List II
Chemicals, DEA Forms 486, 486A
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott Brinks, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
[OMB Number 1117–0023]
SUMMARY:
34239
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Import/Export Declaration for List I and
List II Chemicals.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 486, 486A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected public (Primary):
Business or other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Section 1018 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 971) and
Title 21 Code of Federal Regulations (21
CFR) Part 1313 require any persons who
import, export, or conduct international
transactions involving list I and list II
chemicals are required to establish a
system of recordkeeping and report
certain information regarding those
transactions to DEA. The chemicals
subject to control are used in the
clandestine manufacture of controlled
substances. The reports of domestic,
import, and export regulated
transactions in listed chemicals are
submitted electronically through the
Diversion Control Division secure
network application. Any person who
desires to import non-narcotic
substances in schedules III, IV, and V
must electronically file their return
information. Any person who desires to
export non-narcotic substances in
schedules III and IV and any other
substance in schedule V is also required
to electronically file a controlled
substances import declaration/
controlled substance export invoice.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The below table presents
information regarding the number of
E:\FR\FM\03JNN1.SGM
03JNN1
Agencies
[Federal Register Volume 85, Number 107 (Wednesday, June 3, 2020)]
[Notices]
[Pages 34238-34239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11932]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0024]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Report of Loss or Disappearance of Listed Chemicals and
Regulated Transactions in Tableting/Encapsulating Machines; DEA Forms
107, 452
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
August 3, 2020.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Scott Brinks, Diversion Control
Division, Drug Enforcement Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362-
3261.
SUPPLEMENTARY INFORMATION:
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
[[Page 34239]]
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Report of Loss or Disappearance of
Listed Chemicals and Regulated Transactions in Tableting/Encapsulating
Machines.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Forms 107 and 452. The
applicable component within the Department of Justice is the Drug
Enforcement Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: Each regulated person is required to report any unusual
or excessive loss or disappearance of a listed chemical, and any
regulated transaction in a tableting or encapsulating machine, to
include any domestic regulated transaction in a tableting or
encapsulating machine and any import or export of a tableting or
encapsulating machine. 21 U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR
1310.05(a)(1), (3)-(4); 21 CFR 1310.05(c).
Regulated persons include manufacturers, distributors, importers,
and exporters of listed chemicals, tableting machines, or encapsulating
machines, or persons who serve as brokers or traders for international
transactions involving a listed chemical, tableting machine, or
encapsulating machine. 21 CFR 1300.02(b). Both reports will be
submitted electronically.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: DEA estimates that
2,331 persons respond as needed to this collection. Responses take 20
minutes.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates that this collection takes
1,276 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: May 28, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-11932 Filed 6-2-20; 8:45 am]
BILLING CODE 4410-09-P